Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice
Fuling-Zexie (FZ) formula, a traditional Chinese herbal prescription composed of Poria cocos (Schwan.) Wolf. (Poria), Pueraria lobate (Willd.) Howe. (Puerariae Lobatae Radix), Alisma orientale (Sam.) Julep. (Alismatis Rhizoma), and Atractylodes lancea (Thunb.) Dc. (Atractylodis Rhizoma), has been cl...
Gespeichert in:
| Veröffentlicht in: | Journal of ethnopharmacology 2024-01, Vol.319, p.117262-117262, Article 117262 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 117262 |
|---|---|
| container_issue | |
| container_start_page | 117262 |
| container_title | Journal of ethnopharmacology |
| container_volume | 319 |
| creator | Lu, Meixi Yin, Jiyuan Xu, Tianshu Dai, Xuan Liu, Tianyuan Zhang, Yueyi Wang, Shan Liu, Yage Shi, Hanfen Zhang, Yanfei Mo, Fangfang Sukhorukov, Vasily Orekhov, Alexander N. Gao, Sihua Wang, Lili Zhang, Dongwei |
| description | Fuling-Zexie (FZ) formula, a traditional Chinese herbal prescription composed of Poria cocos (Schwan.) Wolf. (Poria), Pueraria lobate (Willd.) Howe. (Puerariae Lobatae Radix), Alisma orientale (Sam.) Julep. (Alismatis Rhizoma), and Atractylodes lancea (Thunb.) Dc. (Atractylodis Rhizoma), has been clinically used to ameliorate hyperuricemia (HUA) and its associated renal injury.
This study aims to explore the action and mechanism of FZ on renal inflammation and dysfunction caused by HUA.
FZ was orally administered to rapid HUA mouse induced by potassium oxonate (PO) and hypoxanthine (HX) for 7 days. Serum levels of uric acid (UA), creatinine (CRE), blood urea nitrogen (BUN), xanthine oxidase (XOD), adenosine deaminase (ADA), alanine aminotransferase (ALT), aspartate aminotransferase (AST), urine levels of UA, CRE and urinary albumin were determined by biochemical assays. Serum levels of interleukin (IL)-1β and IL-6 were tested by ELISA. Hematoxylin-eosin and Masson staining were used to examine kidney and liver histopathological alterations. The expressions of renal glucose transporter 9 (GLUT9), ATP-binding cassette subfamily G member 2 (ABCG2), organic anion transporter 1 (OAT1), phospho-janus kinase 2 (p-JAK2), p-signal transducer and activator of transcription 3 (p-STAT3), suppression of cytokine signaling 3 (SOCS3), NLR family pyrin domain containing 3 (NLRP3), apoptosis-associated speck-like protein (ASC), and cleaved-cysteinyl aspartate specific proteinase-1 (cleaved-Cas-1) were detected by western blots. The potential protein targets and pathways of FZ intervention on HUA were predicted by network pharmacology. The constituents in FZ aqueous extract were analyzed by UPLC-MS.
FZ reduced serum UA, CRE, BUN, and urinary albumin and increased urine UA, CRE levels in HUA mice. In addition, the treatment with FZ to HUA mice inhibited the elevated serum levels of XOD and ADA, and regulated renal urate transports including OAT1, GLUT9 and ABCG2. FZ also attenuated kidney inflammation and fibrosis and downregulated the expressions of IL-1β, p-JAK2, p-STAT3, SOCS3, IL-6, NLRP3, ASC, and cleaved-Cas-1. Thirteen compounds were identified in the FG, including L-phenylalanine, D-tryptophan, 3′-hydroxypuerarin, Puerarin, 3′-Methoxy Puerarin, Daidzin, Pueroside A, formononetin-8-C- [xylosyl (1→6)]-glucoside, Ononin, Alisol I 23-acetate, 16-oxo-alisol A, Alisol C and Alisol A.
FZ inhibits serum UA generation and promotes urine UA excretion as well as attenuates kidn |
| doi_str_mv | 10.1016/j.jep.2023.117262 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153183972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378874123011327</els_id><sourcerecordid>2872807630</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-faec623e909d8258941f0c5d6a8e3a4835082f7ce2bfd8f0ed204826cf4486603</originalsourceid><addsrcrecordid>eNqFkU9vEzEQxS1EJULhA3Dzkcum_rO7dsQpqmihjaBqw4WL5XrHzUS73sX2VuRD8J1xCGc4jTT6vTea9wh5x9mSM95e7Jd7mJaCCbnkXIlWvCALrpWoVKPkS7JgUulKq5q_Iq9T2jPGFK_Zgvy6mnsMT9V3-IlA_RiHubfU5gxhthkS3R0miHNEBwPaCkM3O-hogGkXx8nm3YHa0FEMO3zEnOjN-lZcPGzXW0kTPgV7NP9DfNnc38nC-d4Og03jANS6jM824xjKng7lxBty5m2f4O3feU6-XX3cXn6qNl-vP1-uN5WTvMmVt-BaIWHFVp0WjV7V3DPXdK3VIG2tZcO08MqBePSd9gw6wWotWufrWrctk-fk_cl3iuOPGVI2AyYHfW8DjHMy5YrkWq6U-C8qSsiaqVYeXfkJdXFMKYI3U8TBxoPhzBxbMntTWjLHlsyppaL5cNJAefcZIZrkEELJGCO4bLoR_6H-DZBUm3E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2872807630</pqid></control><display><type>article</type><title>Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice</title><source>Elsevier ScienceDirect Journals</source><creator>Lu, Meixi ; Yin, Jiyuan ; Xu, Tianshu ; Dai, Xuan ; Liu, Tianyuan ; Zhang, Yueyi ; Wang, Shan ; Liu, Yage ; Shi, Hanfen ; Zhang, Yanfei ; Mo, Fangfang ; Sukhorukov, Vasily ; Orekhov, Alexander N. ; Gao, Sihua ; Wang, Lili ; Zhang, Dongwei</creator><creatorcontrib>Lu, Meixi ; Yin, Jiyuan ; Xu, Tianshu ; Dai, Xuan ; Liu, Tianyuan ; Zhang, Yueyi ; Wang, Shan ; Liu, Yage ; Shi, Hanfen ; Zhang, Yanfei ; Mo, Fangfang ; Sukhorukov, Vasily ; Orekhov, Alexander N. ; Gao, Sihua ; Wang, Lili ; Zhang, Dongwei</creatorcontrib><description>Fuling-Zexie (FZ) formula, a traditional Chinese herbal prescription composed of Poria cocos (Schwan.) Wolf. (Poria), Pueraria lobate (Willd.) Howe. (Puerariae Lobatae Radix), Alisma orientale (Sam.) Julep. (Alismatis Rhizoma), and Atractylodes lancea (Thunb.) Dc. (Atractylodis Rhizoma), has been clinically used to ameliorate hyperuricemia (HUA) and its associated renal injury.
This study aims to explore the action and mechanism of FZ on renal inflammation and dysfunction caused by HUA.
FZ was orally administered to rapid HUA mouse induced by potassium oxonate (PO) and hypoxanthine (HX) for 7 days. Serum levels of uric acid (UA), creatinine (CRE), blood urea nitrogen (BUN), xanthine oxidase (XOD), adenosine deaminase (ADA), alanine aminotransferase (ALT), aspartate aminotransferase (AST), urine levels of UA, CRE and urinary albumin were determined by biochemical assays. Serum levels of interleukin (IL)-1β and IL-6 were tested by ELISA. Hematoxylin-eosin and Masson staining were used to examine kidney and liver histopathological alterations. The expressions of renal glucose transporter 9 (GLUT9), ATP-binding cassette subfamily G member 2 (ABCG2), organic anion transporter 1 (OAT1), phospho-janus kinase 2 (p-JAK2), p-signal transducer and activator of transcription 3 (p-STAT3), suppression of cytokine signaling 3 (SOCS3), NLR family pyrin domain containing 3 (NLRP3), apoptosis-associated speck-like protein (ASC), and cleaved-cysteinyl aspartate specific proteinase-1 (cleaved-Cas-1) were detected by western blots. The potential protein targets and pathways of FZ intervention on HUA were predicted by network pharmacology. The constituents in FZ aqueous extract were analyzed by UPLC-MS.
FZ reduced serum UA, CRE, BUN, and urinary albumin and increased urine UA, CRE levels in HUA mice. In addition, the treatment with FZ to HUA mice inhibited the elevated serum levels of XOD and ADA, and regulated renal urate transports including OAT1, GLUT9 and ABCG2. FZ also attenuated kidney inflammation and fibrosis and downregulated the expressions of IL-1β, p-JAK2, p-STAT3, SOCS3, IL-6, NLRP3, ASC, and cleaved-Cas-1. Thirteen compounds were identified in the FG, including L-phenylalanine, D-tryptophan, 3′-hydroxypuerarin, Puerarin, 3′-Methoxy Puerarin, Daidzin, Pueroside A, formononetin-8-C- [xylosyl (1→6)]-glucoside, Ononin, Alisol I 23-acetate, 16-oxo-alisol A, Alisol C and Alisol A.
FZ inhibits serum UA generation and promotes urine UA excretion as well as attenuates kidney inflammation and fibrosis in HUA mouse with nephropathy. The underlying mechanism of its action may be associated with suppression of the JAK2/STAT3 signaling pathway and NLRP3 inflammasome activation. This formula may offer a novel source for developing anti-HUA drugs.
[Display omitted]
•Fuling-Zexie (FZ) formula promotes uric acid metabolism in hyperuricemia mouse.•FZ attenuates renal inflammation and fibrosis in hyperuricemia mouse.•FZ may limit NLRP3 inflammasome activation and JAK2/STST3 signaling in the kidney of hyperuricemia mouse.</description><identifier>ISSN: 0378-8741</identifier><identifier>EISSN: 1872-7573</identifier><identifier>DOI: 10.1016/j.jep.2023.117262</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>ABC transporters ; adenosine deaminase ; alanine transaminase ; albumins ; Alisma orientale ; Alisols ; aspartate transaminase ; aspartic acid ; Atractylodes lancea ; blood serum ; creatinine ; daidzin ; domain ; excretion ; family ; fibrosis ; Fuling-Zexie (FZ) formula ; glucose transporters ; histopathology ; Hyperuricemia ; hypoxanthine ; inflammasomes ; inflammation ; interleukin-6 ; JAK2/STAT3 ; kidney diseases ; kidneys ; liver ; mice ; NLRP3 inflammasome ; pharmacology ; phenylalanine ; Poria ; potassium ; Pueraria ; Renal dysfunction ; rhizomes ; traditional medicine ; transactivators ; urea nitrogen ; uric acid ; urine ; xanthine oxidase</subject><ispartof>Journal of ethnopharmacology, 2024-01, Vol.319, p.117262-117262, Article 117262</ispartof><rights>2023 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c315t-faec623e909d8258941f0c5d6a8e3a4835082f7ce2bfd8f0ed204826cf4486603</cites><orcidid>0000-0002-0312-3773 ; 0000-0002-7793-1482</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378874123011327$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Lu, Meixi</creatorcontrib><creatorcontrib>Yin, Jiyuan</creatorcontrib><creatorcontrib>Xu, Tianshu</creatorcontrib><creatorcontrib>Dai, Xuan</creatorcontrib><creatorcontrib>Liu, Tianyuan</creatorcontrib><creatorcontrib>Zhang, Yueyi</creatorcontrib><creatorcontrib>Wang, Shan</creatorcontrib><creatorcontrib>Liu, Yage</creatorcontrib><creatorcontrib>Shi, Hanfen</creatorcontrib><creatorcontrib>Zhang, Yanfei</creatorcontrib><creatorcontrib>Mo, Fangfang</creatorcontrib><creatorcontrib>Sukhorukov, Vasily</creatorcontrib><creatorcontrib>Orekhov, Alexander N.</creatorcontrib><creatorcontrib>Gao, Sihua</creatorcontrib><creatorcontrib>Wang, Lili</creatorcontrib><creatorcontrib>Zhang, Dongwei</creatorcontrib><title>Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice</title><title>Journal of ethnopharmacology</title><description>Fuling-Zexie (FZ) formula, a traditional Chinese herbal prescription composed of Poria cocos (Schwan.) Wolf. (Poria), Pueraria lobate (Willd.) Howe. (Puerariae Lobatae Radix), Alisma orientale (Sam.) Julep. (Alismatis Rhizoma), and Atractylodes lancea (Thunb.) Dc. (Atractylodis Rhizoma), has been clinically used to ameliorate hyperuricemia (HUA) and its associated renal injury.
This study aims to explore the action and mechanism of FZ on renal inflammation and dysfunction caused by HUA.
FZ was orally administered to rapid HUA mouse induced by potassium oxonate (PO) and hypoxanthine (HX) for 7 days. Serum levels of uric acid (UA), creatinine (CRE), blood urea nitrogen (BUN), xanthine oxidase (XOD), adenosine deaminase (ADA), alanine aminotransferase (ALT), aspartate aminotransferase (AST), urine levels of UA, CRE and urinary albumin were determined by biochemical assays. Serum levels of interleukin (IL)-1β and IL-6 were tested by ELISA. Hematoxylin-eosin and Masson staining were used to examine kidney and liver histopathological alterations. The expressions of renal glucose transporter 9 (GLUT9), ATP-binding cassette subfamily G member 2 (ABCG2), organic anion transporter 1 (OAT1), phospho-janus kinase 2 (p-JAK2), p-signal transducer and activator of transcription 3 (p-STAT3), suppression of cytokine signaling 3 (SOCS3), NLR family pyrin domain containing 3 (NLRP3), apoptosis-associated speck-like protein (ASC), and cleaved-cysteinyl aspartate specific proteinase-1 (cleaved-Cas-1) were detected by western blots. The potential protein targets and pathways of FZ intervention on HUA were predicted by network pharmacology. The constituents in FZ aqueous extract were analyzed by UPLC-MS.
FZ reduced serum UA, CRE, BUN, and urinary albumin and increased urine UA, CRE levels in HUA mice. In addition, the treatment with FZ to HUA mice inhibited the elevated serum levels of XOD and ADA, and regulated renal urate transports including OAT1, GLUT9 and ABCG2. FZ also attenuated kidney inflammation and fibrosis and downregulated the expressions of IL-1β, p-JAK2, p-STAT3, SOCS3, IL-6, NLRP3, ASC, and cleaved-Cas-1. Thirteen compounds were identified in the FG, including L-phenylalanine, D-tryptophan, 3′-hydroxypuerarin, Puerarin, 3′-Methoxy Puerarin, Daidzin, Pueroside A, formononetin-8-C- [xylosyl (1→6)]-glucoside, Ononin, Alisol I 23-acetate, 16-oxo-alisol A, Alisol C and Alisol A.
FZ inhibits serum UA generation and promotes urine UA excretion as well as attenuates kidney inflammation and fibrosis in HUA mouse with nephropathy. The underlying mechanism of its action may be associated with suppression of the JAK2/STAT3 signaling pathway and NLRP3 inflammasome activation. This formula may offer a novel source for developing anti-HUA drugs.
[Display omitted]
•Fuling-Zexie (FZ) formula promotes uric acid metabolism in hyperuricemia mouse.•FZ attenuates renal inflammation and fibrosis in hyperuricemia mouse.•FZ may limit NLRP3 inflammasome activation and JAK2/STST3 signaling in the kidney of hyperuricemia mouse.</description><subject>ABC transporters</subject><subject>adenosine deaminase</subject><subject>alanine transaminase</subject><subject>albumins</subject><subject>Alisma orientale</subject><subject>Alisols</subject><subject>aspartate transaminase</subject><subject>aspartic acid</subject><subject>Atractylodes lancea</subject><subject>blood serum</subject><subject>creatinine</subject><subject>daidzin</subject><subject>domain</subject><subject>excretion</subject><subject>family</subject><subject>fibrosis</subject><subject>Fuling-Zexie (FZ) formula</subject><subject>glucose transporters</subject><subject>histopathology</subject><subject>Hyperuricemia</subject><subject>hypoxanthine</subject><subject>inflammasomes</subject><subject>inflammation</subject><subject>interleukin-6</subject><subject>JAK2/STAT3</subject><subject>kidney diseases</subject><subject>kidneys</subject><subject>liver</subject><subject>mice</subject><subject>NLRP3 inflammasome</subject><subject>pharmacology</subject><subject>phenylalanine</subject><subject>Poria</subject><subject>potassium</subject><subject>Pueraria</subject><subject>Renal dysfunction</subject><subject>rhizomes</subject><subject>traditional medicine</subject><subject>transactivators</subject><subject>urea nitrogen</subject><subject>uric acid</subject><subject>urine</subject><subject>xanthine oxidase</subject><issn>0378-8741</issn><issn>1872-7573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkU9vEzEQxS1EJULhA3Dzkcum_rO7dsQpqmihjaBqw4WL5XrHzUS73sX2VuRD8J1xCGc4jTT6vTea9wh5x9mSM95e7Jd7mJaCCbnkXIlWvCALrpWoVKPkS7JgUulKq5q_Iq9T2jPGFK_Zgvy6mnsMT9V3-IlA_RiHubfU5gxhthkS3R0miHNEBwPaCkM3O-hogGkXx8nm3YHa0FEMO3zEnOjN-lZcPGzXW0kTPgV7NP9DfNnc38nC-d4Og03jANS6jM824xjKng7lxBty5m2f4O3feU6-XX3cXn6qNl-vP1-uN5WTvMmVt-BaIWHFVp0WjV7V3DPXdK3VIG2tZcO08MqBePSd9gw6wWotWufrWrctk-fk_cl3iuOPGVI2AyYHfW8DjHMy5YrkWq6U-C8qSsiaqVYeXfkJdXFMKYI3U8TBxoPhzBxbMntTWjLHlsyppaL5cNJAefcZIZrkEELJGCO4bLoR_6H-DZBUm3E</recordid><startdate>20240130</startdate><enddate>20240130</enddate><creator>Lu, Meixi</creator><creator>Yin, Jiyuan</creator><creator>Xu, Tianshu</creator><creator>Dai, Xuan</creator><creator>Liu, Tianyuan</creator><creator>Zhang, Yueyi</creator><creator>Wang, Shan</creator><creator>Liu, Yage</creator><creator>Shi, Hanfen</creator><creator>Zhang, Yanfei</creator><creator>Mo, Fangfang</creator><creator>Sukhorukov, Vasily</creator><creator>Orekhov, Alexander N.</creator><creator>Gao, Sihua</creator><creator>Wang, Lili</creator><creator>Zhang, Dongwei</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0000-0002-0312-3773</orcidid><orcidid>https://orcid.org/0000-0002-7793-1482</orcidid></search><sort><creationdate>20240130</creationdate><title>Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice</title><author>Lu, Meixi ; Yin, Jiyuan ; Xu, Tianshu ; Dai, Xuan ; Liu, Tianyuan ; Zhang, Yueyi ; Wang, Shan ; Liu, Yage ; Shi, Hanfen ; Zhang, Yanfei ; Mo, Fangfang ; Sukhorukov, Vasily ; Orekhov, Alexander N. ; Gao, Sihua ; Wang, Lili ; Zhang, Dongwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-faec623e909d8258941f0c5d6a8e3a4835082f7ce2bfd8f0ed204826cf4486603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ABC transporters</topic><topic>adenosine deaminase</topic><topic>alanine transaminase</topic><topic>albumins</topic><topic>Alisma orientale</topic><topic>Alisols</topic><topic>aspartate transaminase</topic><topic>aspartic acid</topic><topic>Atractylodes lancea</topic><topic>blood serum</topic><topic>creatinine</topic><topic>daidzin</topic><topic>domain</topic><topic>excretion</topic><topic>family</topic><topic>fibrosis</topic><topic>Fuling-Zexie (FZ) formula</topic><topic>glucose transporters</topic><topic>histopathology</topic><topic>Hyperuricemia</topic><topic>hypoxanthine</topic><topic>inflammasomes</topic><topic>inflammation</topic><topic>interleukin-6</topic><topic>JAK2/STAT3</topic><topic>kidney diseases</topic><topic>kidneys</topic><topic>liver</topic><topic>mice</topic><topic>NLRP3 inflammasome</topic><topic>pharmacology</topic><topic>phenylalanine</topic><topic>Poria</topic><topic>potassium</topic><topic>Pueraria</topic><topic>Renal dysfunction</topic><topic>rhizomes</topic><topic>traditional medicine</topic><topic>transactivators</topic><topic>urea nitrogen</topic><topic>uric acid</topic><topic>urine</topic><topic>xanthine oxidase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Meixi</creatorcontrib><creatorcontrib>Yin, Jiyuan</creatorcontrib><creatorcontrib>Xu, Tianshu</creatorcontrib><creatorcontrib>Dai, Xuan</creatorcontrib><creatorcontrib>Liu, Tianyuan</creatorcontrib><creatorcontrib>Zhang, Yueyi</creatorcontrib><creatorcontrib>Wang, Shan</creatorcontrib><creatorcontrib>Liu, Yage</creatorcontrib><creatorcontrib>Shi, Hanfen</creatorcontrib><creatorcontrib>Zhang, Yanfei</creatorcontrib><creatorcontrib>Mo, Fangfang</creatorcontrib><creatorcontrib>Sukhorukov, Vasily</creatorcontrib><creatorcontrib>Orekhov, Alexander N.</creatorcontrib><creatorcontrib>Gao, Sihua</creatorcontrib><creatorcontrib>Wang, Lili</creatorcontrib><creatorcontrib>Zhang, Dongwei</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Journal of ethnopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Meixi</au><au>Yin, Jiyuan</au><au>Xu, Tianshu</au><au>Dai, Xuan</au><au>Liu, Tianyuan</au><au>Zhang, Yueyi</au><au>Wang, Shan</au><au>Liu, Yage</au><au>Shi, Hanfen</au><au>Zhang, Yanfei</au><au>Mo, Fangfang</au><au>Sukhorukov, Vasily</au><au>Orekhov, Alexander N.</au><au>Gao, Sihua</au><au>Wang, Lili</au><au>Zhang, Dongwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice</atitle><jtitle>Journal of ethnopharmacology</jtitle><date>2024-01-30</date><risdate>2024</risdate><volume>319</volume><spage>117262</spage><epage>117262</epage><pages>117262-117262</pages><artnum>117262</artnum><issn>0378-8741</issn><eissn>1872-7573</eissn><abstract>Fuling-Zexie (FZ) formula, a traditional Chinese herbal prescription composed of Poria cocos (Schwan.) Wolf. (Poria), Pueraria lobate (Willd.) Howe. (Puerariae Lobatae Radix), Alisma orientale (Sam.) Julep. (Alismatis Rhizoma), and Atractylodes lancea (Thunb.) Dc. (Atractylodis Rhizoma), has been clinically used to ameliorate hyperuricemia (HUA) and its associated renal injury.
This study aims to explore the action and mechanism of FZ on renal inflammation and dysfunction caused by HUA.
FZ was orally administered to rapid HUA mouse induced by potassium oxonate (PO) and hypoxanthine (HX) for 7 days. Serum levels of uric acid (UA), creatinine (CRE), blood urea nitrogen (BUN), xanthine oxidase (XOD), adenosine deaminase (ADA), alanine aminotransferase (ALT), aspartate aminotransferase (AST), urine levels of UA, CRE and urinary albumin were determined by biochemical assays. Serum levels of interleukin (IL)-1β and IL-6 were tested by ELISA. Hematoxylin-eosin and Masson staining were used to examine kidney and liver histopathological alterations. The expressions of renal glucose transporter 9 (GLUT9), ATP-binding cassette subfamily G member 2 (ABCG2), organic anion transporter 1 (OAT1), phospho-janus kinase 2 (p-JAK2), p-signal transducer and activator of transcription 3 (p-STAT3), suppression of cytokine signaling 3 (SOCS3), NLR family pyrin domain containing 3 (NLRP3), apoptosis-associated speck-like protein (ASC), and cleaved-cysteinyl aspartate specific proteinase-1 (cleaved-Cas-1) were detected by western blots. The potential protein targets and pathways of FZ intervention on HUA were predicted by network pharmacology. The constituents in FZ aqueous extract were analyzed by UPLC-MS.
FZ reduced serum UA, CRE, BUN, and urinary albumin and increased urine UA, CRE levels in HUA mice. In addition, the treatment with FZ to HUA mice inhibited the elevated serum levels of XOD and ADA, and regulated renal urate transports including OAT1, GLUT9 and ABCG2. FZ also attenuated kidney inflammation and fibrosis and downregulated the expressions of IL-1β, p-JAK2, p-STAT3, SOCS3, IL-6, NLRP3, ASC, and cleaved-Cas-1. Thirteen compounds were identified in the FG, including L-phenylalanine, D-tryptophan, 3′-hydroxypuerarin, Puerarin, 3′-Methoxy Puerarin, Daidzin, Pueroside A, formononetin-8-C- [xylosyl (1→6)]-glucoside, Ononin, Alisol I 23-acetate, 16-oxo-alisol A, Alisol C and Alisol A.
FZ inhibits serum UA generation and promotes urine UA excretion as well as attenuates kidney inflammation and fibrosis in HUA mouse with nephropathy. The underlying mechanism of its action may be associated with suppression of the JAK2/STAT3 signaling pathway and NLRP3 inflammasome activation. This formula may offer a novel source for developing anti-HUA drugs.
[Display omitted]
•Fuling-Zexie (FZ) formula promotes uric acid metabolism in hyperuricemia mouse.•FZ attenuates renal inflammation and fibrosis in hyperuricemia mouse.•FZ may limit NLRP3 inflammasome activation and JAK2/STST3 signaling in the kidney of hyperuricemia mouse.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.jep.2023.117262</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0312-3773</orcidid><orcidid>https://orcid.org/0000-0002-7793-1482</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0378-8741 |
| ispartof | Journal of ethnopharmacology, 2024-01, Vol.319, p.117262-117262, Article 117262 |
| issn | 0378-8741 1872-7573 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3153183972 |
| source | Elsevier ScienceDirect Journals |
| subjects | ABC transporters adenosine deaminase alanine transaminase albumins Alisma orientale Alisols aspartate transaminase aspartic acid Atractylodes lancea blood serum creatinine daidzin domain excretion family fibrosis Fuling-Zexie (FZ) formula glucose transporters histopathology Hyperuricemia hypoxanthine inflammasomes inflammation interleukin-6 JAK2/STAT3 kidney diseases kidneys liver mice NLRP3 inflammasome pharmacology phenylalanine Poria potassium Pueraria Renal dysfunction rhizomes traditional medicine transactivators urea nitrogen uric acid urine xanthine oxidase |
| title | Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A01%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fuling-Zexie%20formula%20attenuates%20hyperuricemia-induced%20nephropathy%20and%20inhibits%20JAK2/STAT3%20signaling%20and%20NLRP3%20inflammasome%20activation%20in%20mice&rft.jtitle=Journal%20of%20ethnopharmacology&rft.au=Lu,%20Meixi&rft.date=2024-01-30&rft.volume=319&rft.spage=117262&rft.epage=117262&rft.pages=117262-117262&rft.artnum=117262&rft.issn=0378-8741&rft.eissn=1872-7573&rft_id=info:doi/10.1016/j.jep.2023.117262&rft_dat=%3Cproquest_cross%3E2872807630%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2872807630&rft_id=info:pmid/&rft_els_id=S0378874123011327&rfr_iscdi=true |